ExAdEx-Innov at Cosmetic-360 2024 in Paris

Let’s explore innovation at the 10th edition of COSMETIC 360 tradeshow in Paris in October 2024! We are pleased to announce our participation in the COSMETIC 360 exhibition, which will be held in Paris on October 16th and 17th 2024. COSMETIC 360 is the global showcase of innovation for the cosmetic industry. This key event […]

ExAdEx NAM organoids to reduce animal experimentation

Organoid models developed by ExAdEx-Innov and collaborators presented at the 3R LÄND CONFERENCE 2024 in Tübingen (Germany) Latest work from ExAdEx-Innov team on clinically relevant non-animal method (NAM) for human adipose tissue research was selected for a poster presentation at the 3R LÄND Conference 2024 organized by the 3R-Center Tübingen for In vitro Models and […]

ExAdEx-Innov at European Congress on Obesity 2024

Scientific work performed by ExAdEx-Innov researchers and collaborators will be presented during European Congress on Obesity ECO 2024 Latest work on adipose tissue and obesity performed by our researchers and collaborators has been selected for a poster presentation at the 31st European Congress on Obesity (ECO) 2024 in Venice, Italy. Poster presentation will take place […]

French Research Tax Credit (Crédit Impôt Recherche) approval

ExAdEx-Innov has received approval from the French Ministry of Research as a service provider eligible to French Research Tax Credit (Agrément CIR, Crédit Impôt Recherche) As an approved subcontractor, research and development studies performed by French companies at ExAdEx-Innov are eligible to a 30% Tax Credit. The purpose of CIR, Crédit Impôt Recherche (Research Tax […]

Integrating 2D human stem cell model to enlarge R&D platform tools

ExAdEx-Innov announces the signature of a licence agreement with CNRS Innovation on human stem cell model to enlarge R&D platform tools from cells to tissue With the aim of integrating complementary models to its proprietary platform and strengthening the panel of research and development projects covered, ExAdEx-Innov has signed a licence agreement with CNRS Innovation […]

ExAdEx-Innov at IMCAS World Congress 2024

ExAdEx attending IMCAS 2024

ExAdEx-Innov will ATTEND IMCAS WORLD CONGRESS 2024 WITH SPEAKERS AT 3 DIFFERENT SESSIONS IMCAS World Congress is the leading congress in dermatology, plastic surgery and ageing science. IMCAS congresses are medical research conferences bringing together the latest evidence-based techniques from prominent speakers and the newest developments from the major industry players, with the aim to […]

Pitch and booth at BioFIT 2023 Event

ExAdEx-Innov will attend BioFIT 2023, the leading partnering event in Europe for early-stage deals and investments in Life Sciences ExAdEx-Innov has been selected to pitch at the Start-up Slams, showcasing young promising companies seeking to raise a seed financing round. ExAdEx-Innov team will be also present on booth no. B13-A14 held by CNRS (Centre National […]

Attending International Symposium by SFC

ExAdEx-Innov will present its latest works in applied cosmetic research at the 17th Symposium of Société Française de Cosmétologie   Our COO Luigi Formicola and the team will attend the upcoming Symposium of the Cosmetology French Society (Société Française de Cosmétologie, SFC) and present the latest applications of our ExAdEx platform for cosmetic research and […]

Exsymol partners with ExAdEx-Innov to explore new avenues of adipose tissue research

ExAdEx-Innov and Exsymol Monaco are proud to announce their collaboration for innovative cosmetic research.   Exsymol is a leader in the conception of active ingredients for cosmetics and nutrition for more than 45 years, including Silanols, Exsymol’s signature technology: a unique and innovative family of cosmetic actives with a heart of organic silicium. The collaboration between […]

Our biotherapy approach featured in Les Deeptech

Discussing our novel and innovative strategy for an effective and long-term treatment of chronic metabolic diseases associated to obesity.   Our co-founders Vincent Dani and Luigi Formicola are discussing a breakthrough and game-changing approach to treat unmanaged and uncontrolled forms of chronic metabolic diseases associated to obesity through our first-in-class biotherapy ObAdEx in an article […]